北京降压0号治疗原发性高血压病的临床再评价  

Clinical re-evaluation of Beijing Hypotensive No.0 in treatment of essential hypertension

作　　者：何朝珠[1] 邹石[1] 

机构地区：[1]江西医学院医疗门诊部,南昌330006

出　　处：《中国临床药理学与治疗学》2002年第6期548-549,共2页Chinese Journal of Clinical Pharmacology and Therapeutics

摘　　要：目的 :对北京降压 0号治疗原发性高血压病的临床疗效进行再评价。方法 :39例原发性高血压病患者均服用北京降压 0号 1片 ,每日 1次 ,疗程为8周 ,治疗前后分别进行血压、心率、血常规 ,肝肾功能、血脂、血糖、血尿酸的测定。结果 :北京降压 0号对高血压病患者降压效果明显 (P <0 .0 1) ,血常规、肝肾功能、血脂、血糖、血尿酸治疗前后对比无明显差异 (P >0 .0 5 ) ,未见严重不良反应。结论 :北京降压AIM: To re evaluate the effects of Beijing Hypotensive No.0 in the treatment of essential hypertension. METHODS: The 39 cases of patients suffered essential hypertension were treated by Beijing Hypotensive NO.0 at 1 tablet each time and once a day. A single course of treatment lasted for eight weeks. The trial was evaluated with blood pressure, heart rate, blood routine examination, hepatic and kidney function, blood sugar, blood lipid, and blood uric acid before and after the treatment. RESULTS: Beijing Hypotensive NO.0 could significantly relieve hypertension (P<0.01); no differences were shown in blood routine examination, hepatic and kidney function, blood lipid, blood sugar, and blood uric acid (P>0.05). CONCLUSION: Beijing hypetensive No.0 is an effective and safe agent in the treatment of essential hypertension.

关 键 词：北京降压0号 高血压 再评价 

分 类 号：R972.4[医药卫生—药品] R969.[医药卫生—药学]